Human babesiosis in Europe

Human babesiosis in Europe came to medical attention in 1957 and until now 19 cases have been reported, most of them due to Babesia divergens. The onset of the disease is characterized by hemoglobinuria, high fever and renal failure ensue rapidly. The patients were generally asplenic and resident in...

Full description

Bibliographic Details
Main Authors: P. Brasseur, A. Gorenflot
Format: Article
Language:English
Published: Fundação Oswaldo Cruz (FIOCRUZ) 1992-01-01
Series:Memorias do Instituto Oswaldo Cruz
Subjects:
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0074-02761992000700019
_version_ 1797702981040209920
author P. Brasseur
A. Gorenflot
author_facet P. Brasseur
A. Gorenflot
author_sort P. Brasseur
collection DOAJ
description Human babesiosis in Europe came to medical attention in 1957 and until now 19 cases have been reported, most of them due to Babesia divergens. The onset of the disease is characterized by hemoglobinuria, high fever and renal failure ensue rapidly. The patients were generally asplenic and resident in a rural area. Intraerythrocytic pleomorphic parasites (1-3 µm) observed in stained thin blood smears are essential for Genus diagnosis. Parasitemia varyed from 5 to 80% of red blood cells. Massive blood exchange transfusion (2-3 blood volumes) followed by intravenous clindamycine (3-4 times daily) and oral quinine (600 mg base, 3 times daily) were successfully used in the treatment of three recent cases. Splenectomised individuals should be aware for prevention.
first_indexed 2024-03-12T04:58:51Z
format Article
id doaj.art-8e4d54c197bd45d79529d4d0960797ec
institution Directory Open Access Journal
issn 0074-0276
1678-8060
language English
last_indexed 2024-03-12T04:58:51Z
publishDate 1992-01-01
publisher Fundação Oswaldo Cruz (FIOCRUZ)
record_format Article
series Memorias do Instituto Oswaldo Cruz
spelling doaj.art-8e4d54c197bd45d79529d4d0960797ec2023-09-03T09:14:36ZengFundação Oswaldo Cruz (FIOCRUZ)Memorias do Instituto Oswaldo Cruz0074-02761678-80601992-01-018713113210.1590/S0074-02761992000700019Human babesiosis in EuropeP. BrasseurA. GorenflotHuman babesiosis in Europe came to medical attention in 1957 and until now 19 cases have been reported, most of them due to Babesia divergens. The onset of the disease is characterized by hemoglobinuria, high fever and renal failure ensue rapidly. The patients were generally asplenic and resident in a rural area. Intraerythrocytic pleomorphic parasites (1-3 µm) observed in stained thin blood smears are essential for Genus diagnosis. Parasitemia varyed from 5 to 80% of red blood cells. Massive blood exchange transfusion (2-3 blood volumes) followed by intravenous clindamycine (3-4 times daily) and oral quinine (600 mg base, 3 times daily) were successfully used in the treatment of three recent cases. Splenectomised individuals should be aware for prevention.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0074-02761992000700019human babesiosisBabesia divergensepidemiologytreatment
spellingShingle P. Brasseur
A. Gorenflot
Human babesiosis in Europe
Memorias do Instituto Oswaldo Cruz
human babesiosis
Babesia divergens
epidemiology
treatment
title Human babesiosis in Europe
title_full Human babesiosis in Europe
title_fullStr Human babesiosis in Europe
title_full_unstemmed Human babesiosis in Europe
title_short Human babesiosis in Europe
title_sort human babesiosis in europe
topic human babesiosis
Babesia divergens
epidemiology
treatment
url http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0074-02761992000700019
work_keys_str_mv AT pbrasseur humanbabesiosisineurope
AT agorenflot humanbabesiosisineurope